PUBLICATION
Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis
- Authors
- Piccolo, O., Lincoln, J.D., Melong, N., Orr, B.C., Fernandez, N.R., Borsavage, J., Berman, J.N., Robar, J., Ha, M.N.
- ID
- ZDB-PUB-220202-4
- Date
- 2022
- Source
- Scientific Reports 12: 1559 (Journal)
- Registered Authors
- Berman, Jason, Melong, Nicole, Piccolo, Olivia
- Keywords
- none
- MeSH Terms
-
- Gold*
- PubMed
- 35091583 Full text @ Sci. Rep.
Citation
Piccolo, O., Lincoln, J.D., Melong, N., Orr, B.C., Fernandez, N.R., Borsavage, J., Berman, J.N., Robar, J., Ha, M.N. (2022) Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis. Scientific Reports. 12:1559.
Abstract
Radiotherapy (RT) is an effective cancer treatment modality, but standard RT often causes collateral damage to nearby healthy tissues. To increase therapeutic ratio, radiosensitization via gold nanoparticles (GNPs) has been shown to be effective. One challenge is that megavoltage beams generated by clinical linear accelerators are poor initiators of the photoelectric effect. Previous computer models predicted that a diamond target beam (DTB) will yield 400% more low-energy photons, increasing the probability of interacting with GNPs to enhance the radiation dose by 7.7-fold in the GNP vicinity. After testing DTB radiation coupled with GNPs in multiple cell types, we demonstrate decreased head-and-neck cancer (HNC) cell viability in vitro and enhanced cell-killing in zebrafish xenografts compared to standard RT. HNC cell lines also displayed increased double-stranded DNA breaks with DTB irradiation in the presence of GNPs. This study presents preclinical responses to GNP-enhanced radiotherapy with the novel DTB, providing the first functional data to support the theoretical evidence for radiosensitization via GNPs in this context, and highlighting the potential of this approach to optimize the efficacy of RT in anatomically difficult-to-treat tumors.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping